RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases.
Employment range in NC
Primary site activity
All company activities
Products under development
RBIO-1 for corneal blinding in MPS I patients